NCCN Guidelines Insights: T-Cell Lymphomas, Version 2.2018
Steven M. Horwitz(Memorial Sloan Kettering Cancer Center), Hema Sundar(National Comprehensive Cancer Network), Barbara Pro(The University of Texas MD Anderson Cancer Center), Deepa Jagadeesh(University of Massachusetts Chan Medical School), Jasmine Zain(City of Hope), Ahmad Halwani(University of Utah), Stefan K. Barta(University of Pennsylvania), Ryan A. Wilcox(University of Michigan), Ahmet Doǧan(Memorial Sloan Kettering Cancer Center), Jeffrey A. Barnes(Harvard University), Amitkumar Mehta(University of Alabama at Birmingham), Lubomir Sokol(Moffitt Cancer Center), Saurabh Rajguru(UW Health University Hospital), Y. Oki(The University of Texas MD Anderson Cancer Center), Weiyun Z. Ai(City College of San Francisco), Pallawi Torka(Roswell Park Comprehensive Cancer Center), Andrei R. Shustov(Seattle Cancer Care Alliance), Stephen M. Ansell(Mayo Clinic), Neha Mehta–Shah(The University of Texas MD Anderson Cancer Center), Basem M. William(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Elise A. Olsen(Durham Technical Community College), Michael Y. Choi(University of California San Diego), Richard T. Hoppe(Stanford Medicine), Satish Shanbhag(Florida Cancer Specialists & Research Institute), Eric D. Jacobsen(Dana-Farber Cancer Institute), Matthew A. Lunning(University of Nebraska Medical Center), Mark W. Clemens(The University of Texas MD Anderson Cancer Center), Youn H. Kim(Stanford University), John P. Greer(Vanderbilt University Medical Center), Mary A. Dwyer(National Comprehensive Cancer Network), Bradley M. Haverkos(University of Colorado Denver)
Cited by 79
Related Papers
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
|New England Journal of Medicine|2017|6k
PD-1 Blockade with Nivolumab in Relapsed or Refractory Hodgkin's Lymphoma
|New England Journal of Medicine|2014|3.5k
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
NCCN Task Force Report: Update on the Management of Patients with Gastrointestinal Stromal Tumors
|Journal of the National Comprehensive Cancer Network|2010|1.2k